Identification of an optimal dose of intravenous ketamine for late-life treatment-resistant depression: a Bayesian adaptive randomization trial
Marijn Lijffijt, Nicholas Murphy, Sidra Iqbal, Charles E. Green, Tabish Iqbal, Lee C. Chang, Colin N. Haile, Lorna C. Hirsch, Nithya Ramakrishnan, Dylan A. Fall, Alan C. Swann, Rayan K. Al Jurdi, Sanjay J. Mathew
Topics & Concepts
TolerabilityRandomizationMedicineKetaminePlaceboRandomized controlled trialDepression (economics)AnesthesiaTreatment-resistant depressionInternal medicineMajor depressive disorderAdverse effectAmygdalaMacroeconomicsAlternative medicinePathologyEconomicsTreatment of Major DepressionMental Health Research TopicsFunctional Brain Connectivity Studies